Today, the House passed by voice vote H.R. 3178, the Medicare Part B Improvement Act of 2017. This legislation makes a series of targeted improvements to Medicare Part B programs and includes several bipartisan solutions introduced by Members of the Ways and Means Committee, including Health Subcommittee Chairman Pat Tiberi’s bill to protect patient access to home infusion services.
On the House floor, Tiberi delivered the following remarks:
“I stand today in strong support for H.R. 3178, a package of bipartisan policies centered on improving care for Medicare beneficiaries across several areas.
“Particularly, H.R. 3178 includes my bill introduced with my friend Bill Pascrell that provides a temporary transitional payment for home infusion providers.
“The 21st Century Cures Act created a new reimbursement benefit for home infusion therapies beginning in 2021. This new temporary transitional payment will help bridge the potential gap in care for beneficiaries, and home infusion providers will continue to administer these therapies without risk of going bankrupt.
“This legislation includes other good policies that further encourage giving seniors the choice to receive more care in the comfort of their own homes, as well as expanding access to providers, particularly in rural and needy areas.
“I’d like to thank my colleagues on the Ways and Means Committee for their support. I’d also like to thank my colleagues on the Energy and Commerce Committee for their commitment to working on this issue, especially my counterpart Subcommittee Chairman Michael Burgess, and Chairman Emeritus Fred Upton, who helped pave the way for these policies with passage of the 21st Century Cures Act.
“I would like to conclude with a commitment that this is not the end for policies encouraging care – especially drug infusion – in the home for patients that choose to do so.
“We look forward to working with the Administration to clarify current rules to ensure we successfully implement both this legislation and future policies to ensure inclusion of payments for all drugs needed by the home infusion patient community.”